ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Bicara Therapeutics Inc

Bicara Therapeutics Inc (BCAX)

19.195
-0.98
(-4.83%)
Closed November 18 4:00PM
19.195
0.00
( 0.00% )
Pre Market: 7:00AM

Bicara Therapeutics Inc Financial Summary

The current BCAX market cap is 993.55M. The company's latest EPS is USD -1.0043 and P/E is -19.11.

Quarter End
USD ($)
Total Revenue
Operating Income
Net Income
Year End December 30 2023 2023
USD ($)
Total Revenue 0
Operating Income -39.89M
Net Income -51.99M
Quarter End
USD ($)
Total Assets
Total Liabilities
Total Equity
Year End December 30 2023 2023
USD ($)
Total Assets 233.98M
Total Liabilities 15.47M
Total Equity -148.77M
Quarter End
USD ($)
Operating
Investing
Financing
Year End December 30 2023 2023
USD ($)
Operating -45.63M
Investing -586k
Financing 272.5M
Market Cap 993.55M
Price to Earnings Ratio -19.11
Price to Sales Ratio 0
Price to Cash Ratio 4.31
Price to Book Ratio 4.55
Dividend Yield -

Share Statistics

Shares Outstanding 51.76M
Average Volume (1 week) 300.04k
Average Volume (1 Month) 271.97k
52 Week Change -26.88%
52 Week High 27.95
52 Week Low 18.33
Spread (Intraday) 7.28 (28.55%)

Company Info

Company Name Bicara Therapeutics Inc
Address corporation trust center
wilmington, delaware 19801
Website https://www.bicara.com
Industry pharmaceutical preparations (2834)